These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 16331989)

  • 1. The role of His-18 in amyloid formation by human islet amyloid polypeptide.
    Abedini A; Raleigh DP
    Biochemistry; 2005 Dec; 44(49):16284-91. PubMed ID: 16331989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic beta-cell granule peptides form heteromolecular complexes which inhibit islet amyloid polypeptide fibril formation.
    Jaikaran ET; Nilsson MR; Clark A
    Biochem J; 2004 Feb; 377(Pt 3):709-16. PubMed ID: 14565847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a novel human islet amyloid polypeptide beta-sheet domain and factors influencing fibrillogenesis.
    Jaikaran ET; Higham CE; Serpell LC; Zurdo J; Gross M; Clark A; Fraser PE
    J Mol Biol; 2001 May; 308(3):515-25. PubMed ID: 11327784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the heparin binding site in the N-terminus of human pro-islet amyloid polypeptide: implications for amyloid formation.
    Abedini A; Tracz SM; Cho JH; Raleigh DP
    Biochemistry; 2006 Aug; 45(30):9228-37. PubMed ID: 16866369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design of peptide-based inhibitors of human islet amyloid polypeptide fibrillogenesis.
    Scrocchi LA; Chen Y; Waschuk S; Wang F; Cheung S; Darabie AA; McLaurin J; Fraser PE
    J Mol Biol; 2002 May; 318(3):697-706. PubMed ID: 12054816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Destabilization of human IAPP amyloid fibrils by proline mutations outside of the putative amyloidogenic domain: is there a critical amyloidogenic domain in human IAPP?
    Abedini A; Raleigh DP
    J Mol Biol; 2006 Jan; 355(2):274-81. PubMed ID: 16303136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-based design and study of non-amyloidogenic, double N-methylated IAPP amyloid core sequences as inhibitors of IAPP amyloid formation and cytotoxicity.
    Kapurniotu A; Schmauder A; Tenidis K
    J Mol Biol; 2002 Jan; 315(3):339-50. PubMed ID: 11786016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Residual structure in islet amyloid polypeptide mediates its interactions with soluble insulin.
    Wei L; Jiang P; Yau YH; Summer H; Shochat SG; Mu Y; Pervushin K
    Biochemistry; 2009 Mar; 48(11):2368-76. PubMed ID: 19146426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aromatic interactions are not required for amyloid fibril formation by islet amyloid polypeptide but do influence the rate of fibril formation and fibril morphology.
    Marek P; Abedini A; Song B; Kanungo M; Johnson ME; Gupta R; Zaman W; Wong SS; Raleigh DP
    Biochemistry; 2007 Mar; 46(11):3255-61. PubMed ID: 17311418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low pH acts as inhibitor of membrane damage induced by human islet amyloid polypeptide.
    Khemtémourian L; Doménech E; Doux JP; Koorengevel MC; Killian JA
    J Am Chem Soc; 2011 Oct; 133(39):15598-604. PubMed ID: 21870807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Environmental factors differently affect human and rat IAPP: conformational preferences and membrane interactions of IAPP17-29 peptide derivatives.
    Pappalardo G; Milardi D; Magrì A; Attanasio F; Impellizzeri G; La Rosa C; Grasso D; Rizzarelli E
    Chemistry; 2007; 13(36):10204-15. PubMed ID: 17902185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Membrane permeabilization by Islet Amyloid Polypeptide.
    Engel MF
    Chem Phys Lipids; 2009 Jul; 160(1):1-10. PubMed ID: 19501206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Islet amyloid polypeptide: identification of long-range contacts and local order on the fibrillogenesis pathway.
    Padrick SB; Miranker AD
    J Mol Biol; 2001 May; 308(4):783-94. PubMed ID: 11350174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amyloidogenicity and cytotoxicity of islet amyloid polypeptide.
    Kapurniotu A
    Biopolymers; 2001; 60(6):438-59. PubMed ID: 12209476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rifampicin does not prevent amyloid fibril formation by human islet amyloid polypeptide but does inhibit fibril thioflavin-T interactions: implications for mechanistic studies of beta-cell death.
    Meng F; Marek P; Potter KJ; Verchere CB; Raleigh DP
    Biochemistry; 2008 Jun; 47(22):6016-24. PubMed ID: 18457428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of pressure on islet amyloid polypeptide aggregation: revealing the polymorphic nature of the fibrillation process.
    Radovan D; Smirnovas V; Winter R
    Biochemistry; 2008 Jun; 47(24):6352-60. PubMed ID: 18498175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phospholipid catalysis of diabetic amyloid assembly.
    Knight JD; Miranker AD
    J Mol Biol; 2004 Aug; 341(5):1175-87. PubMed ID: 15321714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid membranes modulate the structure of islet amyloid polypeptide.
    Jayasinghe SA; Langen R
    Biochemistry; 2005 Sep; 44(36):12113-9. PubMed ID: 16142909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amyloid formation by pro-islet amyloid polypeptide processing intermediates: examination of the role of protein heparan sulfate interactions and implications for islet amyloid formation in type 2 diabetes.
    Meng F; Abedini A; Song B; Raleigh DP
    Biochemistry; 2007 Oct; 46(43):12091-9. PubMed ID: 17924651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of IAPP fibrillation at anionic lipid membranes via IAPP-derived amyloid inhibitors and insulin.
    Sellin D; Yan LM; Kapurniotu A; Winter R
    Biophys Chem; 2010 Aug; 150(1-3):73-9. PubMed ID: 20153100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.